HIV Prevention in Primary Care Practice
A PrEP Primer
Are you PrEP’d to Discuss Sexual Health & HIV Prevention?
Emtricitabine/tenofovir alafenamide; January 2020.
AIDS Info. US Department of Health and Human Services.
Emtricitabine/tenofovir disoproxil fumarate; July 2020.
HIV Info. US Department of Health and Human Services.
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts.
Cahill S, et al. AIDS Care. 2017;29(11):1351-1358.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Being PrEPared – preexposure prophylaxis and HIV disparities.
Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295.
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.
The phase 3 DISCOVER study: daily F/TAF or F/TDF for HIV preexposure prophylaxis.
Hare CB, et al. 26th CROI 2019; March 4-7, 2019; Seattle, WA. Abstract 104.
Lifetime risk of a diagnosis of HIV infection in the United States.
Hess KL, et al. Ann Epidemiol. 2017;27(4):238-243.
Phase 3 randomized, controlled DISCOVER study of daily F/TAF or F/TDF for HIV pre-exposure prophylaxis: week 96 results.
Ruane P, et al. 17th European AIDS Conference (EACS); November 6-9, 2019; Basel, Switzerland. Poster PE3/16.
How to incorporate HIV PrEP into your practice.
Stewart J, Stekler JD. J Fam Pract. 2019;68(5):254-261.
eBook Reader
Apple Books | Amazon | Barnes & Noble | Google Play
Clinical Practice Guidelines
Guidance and resources during disruption of STD clinical services; update on STD treatment options.
Centers for Disease Control and Prevention; May 2020.
2015 sexually transmitted diseases treatment guidelines.
Centers for Disease Control and Prevention, 2015; last reviewed December 2019.
Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016.
CDC Stacks. Centers for Disease Control and Prevention; last updated May 2018. Accessed May 1, 2020.
Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People.
Coleman E, et al. 7th ed. East Dundee, Illinois: World Professional Association for Transgender Health; 2012.
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel.
Saag MS, et al. JAMA. 2020. [Epub ahead of print].
Guidelines for prevention and treatment of opportunistic infections in adults and adolescents with HIV.
US Department of Health and Human Services; revised May 2020.
Guidelines for the use of antiretroviral agents in adults and adolescents with HIV.
US Department of Health and Human Services; last updated December 2019.
Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update. A clinical practice guideline.
US Public Health Service. Centers for Disease Control and Prevention; 2018.
Professional Resources
American Academy of HIV Medicine; supporting the HIV care provider and the profession.
Basic statistics.
Centers for Disease Control and Prevention; July 2020.
HIV testing.
Centers for Disease Control and Prevention; 2020.
HIV in the United States by region.
Centers for Disease Control and Prevention; July 2020.
HIV and youth.
Centers for Disease Control and Prevention; May 2020.
Pre-exposure prophylaxis (PrEP).
Centers for Disease Control and Prevention; May 2020.
Taking a sexual history.
Centers for Disease Control and Prevention; April 2020.
PrEP to prevent HIV and promote sexual health.
New York State Department of Health AIDS Institute, Clinical Guidelines Program; July 2020.
TargetHIV.
Sexual History Taking Toolkit; July 2020.
Ending the HIV epidemic: Ready, Set, PrEP.
US Department of Health and Human Services.
Center of Excellence for Transgender Health.
Prevention Science, Department of Medicine; University of California, San Francisco.
National Clinician Consultation Center.
University of California, San Francisco; 2020.
HIV drug interactions.
University of Liverpool (website); September 2020.
Patient Resources
HIV basics.
Centers for Disease Control and Prevention; June 2020.
Prevention for women. Resources on HIV prevention for U.S. women.
HIVE online; 2019.
Get HIV care
HRSA Ryan White HIV/AIDS Program
HIV resources.
National Institutes of Health.
Positively Aware.
Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.
UCSF transgender care.
University of California, San Francisco
HIV Prevention in Primary Care Practice
A PrEP Primer
| Faculty: | Gregory S. Felzien, MD, AAHIVS; Andrea R. Jefferson-Saboor, FNP-C |
| Release: | 10/19/2020 |
| Expiration: | 12/16/2021 |
